Table of Contents

Articles

• Open Access

  Hepatocellular Carcinoma: Up-regulated Circular RNAs Which Mediate Efficacy in Preclinical In Vivo Models

  ULRICH H. WEIDLE and ADAM NOPORA

  Cancer Genomics & Proteomics November 2023, 20 (6) 500-521; DOI: https://doi.org/10.21873/cgp.20401
• Open Access

  p21 Protein Outperforms Clinico-pathological Criteria in Predicting Liver Metastases in Pancreatic Endocrine Tumors

  AEJAZ NASIR, MALIK K. AHMED, JAMES J. SALLER, EVITA B. HENDERSON-JACKSON, MOKENGE P. MALAFA, TIMOTHY J. YEATMAN and DOMENICO COPPOLA

  Cancer Genomics & Proteomics November 2023, 20 (6) 522-530; DOI: https://doi.org/10.21873/cgp.20402
• Open Access

  Inhibition of Increased Invasiveness of Breast Cancer Cells With Acquired Tamoxifen Resistance by Suppression of CYR61

  GERD BAUERSCHMITZ, SILKE HÜCHEL, JULIA GALLWAS and CARSTEN GRÜNDKER

  Cancer Genomics & Proteomics November 2023, 20 (6) 531-538; DOI: https://doi.org/10.21873/cgp.20403
• Open Access

  Molecular Characteristics and Therapeutic Vulnerabilities of Claudin-low Breast Cancers Derived from Cell Line Models

  IOANNIS A. VOUTSADAKIS

  Cancer Genomics & Proteomics November 2023, 20 (6) 539-555; DOI: https://doi.org/10.21873/cgp.20404
• Open Access

  Pathogenetic Dichotomy in Angioleiomyoma

  IOANNIS PANAGOPOULOS, KRISTIN ANDERSEN, MARTA BRUNETTI, LUDMILA GORUNOVA, ILYÁ KOSTOLOMOV, WANJA KILDAL, HANNE REGINE HOGNESTAD, INGVILD LOBMAIER, FRANCESCA MICCI and SVERRE HEIM

  Cancer Genomics & Proteomics November 2023, 20 (6) 556-566; DOI: https://doi.org/10.21873/cgp.20405
• Open Access

  Hsa_circ_0079557 Promotes the Proliferation of Colorectal Cancer Cells Through the hsa_circ_0079557/miR-502-5p/CCND1 Axis

  CHAO YU, XUE HUANG, RENLI HUANG, PEIQI WANG, ZONGDA CAI, ZEYI GUO, QINGNAN LAN, HAODI CAO and JINLONG YU

  Cancer Genomics & Proteomics November 2023, 20 (6) 567-581; DOI: https://doi.org/10.21873/cgp.20406
• Open Access

  SUV39H1 Expression as a Guideline for Omitting Radiotherapy in Lymph Node-positive Triple-negative Breast Cancer Patients

  WEI-LUN HUANG, CHI-WEN LUO, HUEI-SHAN LIN, CHAO-MING HUNG, FANG-MING CHEN, SIN-HUA MOI and MEI-REN PAN

  Cancer Genomics & Proteomics November 2023, 20 (6) 582-591; DOI: https://doi.org/10.21873/cgp.20407
• Open Access

  Using Comparative Proteomics to Identify Protein Signatures in Clear Cell Renal Cell Carcinoma

  JUHEE PARK, EUN HYE LEE, HYUNCHAE SIM, ANN-YAE NA, SO YOUNG CHOI, JAE-WOOK CHUNG, YUN-SOK HA, TAE GYUN KWON, SANGKYU LEE and JUN NYUNG LEE

  Cancer Genomics & Proteomics November 2023, 20 (6) 592-601; DOI: https://doi.org/10.21873/cgp.20408
• Open Access

  Potential Common Molecular Mechanisms Between Periodontitis and Hepatocellular Carcinoma: A Bioinformatic Analysis and Validation

  XIAOMIAO FAN, ZIMIN SONG, WENGUANG QIN, TING YU, BAOGANG PENG and YUQIN SHEN

  Cancer Genomics & Proteomics November 2023, 20 (6) 602-616; DOI: https://doi.org/10.21873/cgp.20409
• Open Access

  Risk Stratification by Tissue GAD1 Expression Level in Curatively Resected Esophageal Squamous Cell Carcinoma

  TAKAYOSHI KISHIDA, MITSURO KANDA, YUSUKE SATO, DAI SHIMIZU, YOSHIKUNI INOKAWA, NORIFUMI HATTORI, MASAMICHI HAYASHI, CHIE TANAKA, GORO NAKAYAMA and YASUHIRO KODERA

  Cancer Genomics & Proteomics November 2023, 20 (6) 617-625; DOI: https://doi.org/10.21873/cgp.20410
• Open Access

  Clinicopathological and Prognostic Values of Telomerase Reverse Transcriptase (TERT) Promoter Mutations in Ovarian Clear Cell Carcinoma for Predicting Tumor Recurrence, Platinum Resistance and Survival

  HYUNWOO YOO and HYUN-SOO KIM

  Cancer Genomics & Proteomics November 2023, 20 (6) 626-636; DOI: https://doi.org/10.21873/cgp.20411